BNR - CIK 0001792267
No parsed quarterly data available for Burning Rock Biotech Ltd yet.
Burning Rock Biotech Ltd reported operating cash flow of -$4.07M for fiscal year 2025. That is up 67.8% from -$12.64M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow grew from -$11.27M (FY 2020) to -$4.07M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.